
Smart LOTO for Safe Operations
Digital lockout-tagout safety
0 ratings
Free
Rating summary
About
Smart LOTO brings lockout-tagout (LOTO) and permit-to-work safety to the field — on the device in every isolator's pocket.
Built for plants, factories, and industrial sites, Smart LOTO digitizes the full energy-isolation workflow — from permit issue through isolation, work verification, and controlled de-isolation — with a verifiable audit trail at every step.
KEY CAPABILITIES
- Permit-to-work, role-aware: initiators, issuers, custodians, isolators, technicians, and safety officers each see exactly what they need to action.
- Smart-lock isolation over Bluetooth: bind a BLE smart lock to an isolation point and apply or remove it with one tap.
- QR verification: scan each isolation point before binding, so the right lock goes on the right point every time.
- Photo evidence and audit trail: every lock-on and lock-off is logged with a timestamp, the operator, the lock ID, and a photo.
- Face-verified check-in: confirm the right worker checks in and out of the work party.
- SIMOPS-aware: when multiple permits share an isolation point, the lock stays in place until the last permit completes - automatically.
- Real-time sync: permits and isolation status stay current across the team and integrate with your permit-to-work system.
Smart LOTO requires an organization account. Contact your safety team or visit smartloto.innvendt.com to get set up.
Show more
+2
What's New in Smart LOTO for Safe Operations
2.13.1
October 12, 2026
• Shared isolation points. Each isolation point now lists every other permit sharing it, and what each one is doing with the lock: holding the padlock, protected by it, released for a machine trial, or de-isolated. • Also protecting. When a padlock is keeping other permits safe, the point says so and names them. • Machine trials on shared points. While a machine trial is running, a point shared with another permit can no longer be released by hand. It is released automatically once every permit sharing it has approved the trial.
More


